The new consortium partners expand CSDR's ability to help accelerate life-saving discoveries and efficiently translate big data into smart data that generates valuable research results.
With the addition of non-profit partners, CSDR is uniquely positioned to not only serve the research community through access to patient-level clinical data from the pharmaceutical industry, but also as a resource through which academic-led clinical trial data now can be shared.
ClinicalStudyDataRequest.com is an online resource giving researchers access to patient-level clinical trial data from 14 pharmaceutical companies across multiple therapeutic areas.
Its multi-sponsor request system provides a secure process for researchers to request access to global clinical trial data through a publicly available website.
An independent review panel reviews data requests received from external researchers. Wellcome Trust provides secretarial support to this panel and oversees the review process.
Ipsen to acquire Memo Therapeutics to expand rare disease portfolio
Eurobio Scientific completes acquisition of CareDx's transplant lab products business
Aspen Neuroscience completes Cohort 3 and 4 dosing in Parkinson's disease trial
Biohaven completes enrolment in opakalim RISE 3 epilepsy study
ADC Therapeutics completes enrolment in Phase 1b ZYNLONTA combination trial
Sanofi reports positive phase 3 results for Nexviazyme in infantile-onset Pompe disease
Zelluna awarded NOK16m research grant for Phase 1 cancer study